Previous Section Index Home Page

30 Jun 2005 : Column 1748W—continued

HEALTH

Alliance Medical

Mr. Kevan Jones: To ask the Secretary of State for Health how many scans Alliance Medical must conduct over the course of its five year contract to provide scanning services in the NHS. [7555]

Mr. Byrne [holding answer 27 June 2005]: 630,000 scans will be delivered over the life of the contract.

Alzheimer's Disease

Mr. Burstow: To ask the Secretary of State for Health pursuant to the answer of 6 June 2005, Official Report, column 414W, on Alzheimer's, if she will place in the Library copies of the background papers concerning the reviews to which she refers. [5627]

Jane Kennedy: Only limited papers are readily available about past reviews that looked at the list of medical conditions that give exemption from prescription
 
30 Jun 2005 : Column 1749W
 
charges. The cost of searching for all available papers would be disproportionately expensive. The readily available information will be placed in the Library.

An internal review of prescription charges was undertaken by Departmental officials in conjunction with Her Majesty's Treasury as part of the formulation of Government policy for the 1998 comprehensive spending review. This work fed into the outcome of the comprehensive spending review, which was published by Her Majesty's Treasury, pursuant to the answer of 2 February 2005, Official Report, column 908W.

Ambulance Services

Sarah Teather: To ask the Secretary of State for Health (1) how many ambulances were available in the NHS in London in each year since 1997; [7470]

(2) how many NHS ambulances there were in London in each of the last five years. [8307]

Jane Kennedy: This information is not collected centrally.

Sarah Teather: To ask the Secretary of State for Health what the average response time was to an emergency call to the ambulance service in each London borough in each year since 1997. [7471]

Jane Kennedy: This information is not collected centrally in the format requested. Data on response times for London Ambulance Service National Health Service Trust is shown in the tables.

Data is available only from 2000–01 which is the year London Ambulance Service NHS Trust introduced prioritisation.

Further information can be found in the statistical bulletin, Ambulance services, England: 2004–05". Copies are available in the Library and on the Department's website at: http://www.dh.gov.uk/assetRoot/04/ll/36/79/04113679.pdf
Percentage of category A calls responded within eight minutes

London
1997–98n/a
1998–99n/a
1999–2000n/a
2000–0141.8
2001–0257.2
2002–0369.1
2003–0476.0
2004–0576.6




n/a=not available.





Percentage of category A calls responded within 14 to 19 minutes

London
1997–98n/a
1998–99n/a
1999–2000n/a
2000–0183.3
2001–0285.7
2002–0388.6
2003–0489.6
2004–0595.9




n/a=not available.




 
30 Jun 2005 : Column 1750W
 

Percentage of category B/C calls responded within 14 to 19minutes

London
1997–98n/a
1998–99n/a
1999–2000n/a
2000–0179.7
2001–0278.5
2002–0379.2
2003–0477.9
2004–0581.2




n/a=not available.




Percentage of urgent journeys with arrival time not more than 15minutes late

London
1997–9879.3
1998–9969.4
1999–200061.0
2000–0150.1
2001–0248.4
2002–0346.7
2003–0450.0
2004–0558.0

Appraisals (National Institute for Health and Clinical Excellence)

Mr. Havard: To ask the Secretary of State for Health how many (a) medical devices and (b) pharmaceutical products were submitted for appraisal to the (i)National Institute for Clinical Excellence in (A) 2003 and (B) 2004 and (ii) National Institute for Health and Clinical Excellence in 2005. [8512]

Jane Kennedy: Details of the appraisal topics referred to the National Institute for Clinical Excellence in 2003 and 2004 and to the National Institute for Health and Clinical Excellence in 2005 are as follows.

In 2003, two work programmes were referred:

Wave 8—April 2003

Pharmaceuticals

Devices

Other


 
30 Jun 2005 : Column 1751W
 

Wave 9—October 2003

Pharmaceuticals

Other

2004

Wave 10—June 2004

Pharmaceuticals


 
30 Jun 2005 : Column 1752W
 

Devices

Wave 11—April 2005

Pharmaceuticals

Other

Mr. Havard: To ask the Secretary of State for Health (1)if she will ask the National Institute for Health and Clinical Excellence to look at ways to speed up its appraisal process; and if she will make a statement; [8513]

(2) if she will ask the National Institute for Health and Clinical Excellence to review its criteria for appraising medical devices. [8514]

Jane Kennedy: The National Institute for Health and Clinical Excellence (NICE) is an independent organisation, which develops its guidance after careful consideration of the available evidence and in consultation with stakeholders. The process by which it develops its guidance is a matter for NICE. Its processes have been developed through wide consultation, are transparent and have been endorsed by the World Health Organisation. NICE reviews its processes regularly in order to identify opportunities for efficiencies in the way they are applied.


Next Section Index Home Page